Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Immunology >> Immunoglobulins >> Receptors
Anti-EPO Receptor antibody [MM-0031-6G7]
See all EPO Receptor products (7) ...
Mouse monoclonal [MM-0031-6G7] to EPO Receptor
Ab56310 recognizes EPO Receptor using western blot. This antibody has been tested to be able to pick up human EPOR around 60-65 kDa under both reducing and non-reducing conditions. However the immunosignal is much stronger under non-reducing conditions so remove beta-mercaptoethanol or DTT from sample buffer.
IHC-P, WB, Flow Cytmore details
Reacts with
Human
Human recombinant EPO Receptor (extracellular domain)
Lyophilised:
Reconstitute with 0.5ml sterile PBS
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Preservative: None
Constituents: PBS
Concentration information loading...
Protein G purified
Monoclonal
MM-0031-6G7
IgG2a
Cardiovascular >> Heart >> Hypertrophy >> Other
Cardiovascular >> Heart >> Apoptosis
Cardiovascular >> Atherosclerosis >> Ischemia / Reperfusion
Stem Cells >> Hematopoietic Progenitors >> Surface Molecules
Cardiovascular >> Angiogenesis >> Angiogenic Factors
Signal Transduction >> Signaling Pathway >> G Protein Signaling >> Small G Proteins >> Other
Immunology >> Immunoglobulins >> Receptors
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - EPO Receptor antibody [MM-0031-6G7] (ab56310)
(enlarge)
Our Abpromise guarantee covers the use of ab56310 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
IHC-P: 1/10 - 1/40.(Proteinase k digestion is required, 20 ug/ml proteinase K (in PBS), digestion at room temperature for 15-30 mins.)
WB: 1/1000 - 1/2000. Use under non reducing condition. Detects a band of approximately 60 kDa (predicted molecular weight: 55 kDa).
Flow Cyt: Use at an assay dependent concentration. (PubMed: 21698228)
Receptor for erythropoietin. Mediates erythropoietin-induced erythroblast proliferation and differentiation. Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some cell types, can also activate STAT1 and STAT3. May also activate the LYN tyrosine kinase.
Isoform EPOR-T acts as a dominant-negative receptor of EPOR-mediated signaling.
Erythroid cells and erythroid progenitor cells. Isoform EPOR-F is the most abundant form in EPO-dependent erythroleukemia cells and in late-stage erythroid progenitors. Isoform EPOR-S and isoform EPOR-T are the predominant forms in bone marrow. Isoform EPOR-T is the most abundant from in early-stage erythroid progenitor cells.
Defects in EPOR are the cause of erythrocytosis familial type 1 (ECYT1) [MIM:133100]. ECYT1 is an autosomal dominant disorder characterized by increased serum red blood cell mass, elevated hemoglobin and hematocrit, hypersensitivity of erythroid progenitors to erythropoietin, erythropoietin low serum levels, and no increase in platelets nor leukocytes. It has a relatively benign course and does not progress to leukemia.
Belongs to the type I cytokine receptor family. Type 1 subfamily.
Contains 1 fibronectin type-III domain.
The WSXWS motif appears to be necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding.
The box 1 motif is required for JAK interaction and/or activation.
Contains 1 copy of a cytoplasmic motif that is referred to as the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is involved in modulation of cellular responses. The phosphorylated ITIM motif can bind the SH2 domain of several SH2-containing phosphatases.
On EPO stimulation, phosphorylated on C-terminal tyrosine residues by JAK2. The phosphotyrosine motifs are also recruitment sites for several SH2-containing proteins and adapter proteins which mediate cell proliferation. Phosphorylation on Tyr-454 is required for PTPN6 interaction, Tyr-426 for PTPN11. Tyr-426 is also required for SOCS3 binding, but Tyr-454/Tyr-456 motif is the preferred binding site.
Ubiquitinated by NOSIP; appears to be either multi-monoubiquitinated or polyubiquitinated. Ubiquitination mediates proliferation and survival of EPO-dependent cells.
Cell membrane and Secreted. Secreted and located to the cell surface.
Target information above from: UniProt accessionP19235
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - EPO Receptor antibody [MM-0031-6G7] (ab56310)
![Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - EPO Receptor antibody [MM-0031-6G7] (ab56310)](/ps/datasheet/images/56/ab56310/EPO-Receptor-Primary-antibodies-ab56310-1.bmp)
Formalin fixed and Paraffin embedded human placenta tissue section was subjected to IHC staining using ab56310 (Proteinase K pretreatment is required).
This product has been referenced in:
See all 3 publications for this product
Publishing research using ab56310? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
